Showing results (1-10 of 138) with videos related to
Sort By:
Pageof 14
The AAPS Journal|June 13, 2025
Dose Optimization of ClpP Agonists Using an In Vitro Microfluidic Perfusion Platform and In Silico Pharmacokinetic-Pharmacodynamic ModelingRonald W Bucher, Lee M Graves, Derek W BartlettChemical Society Reviews|April 19, 2022
Translational PK-PD for targeted protein degradationDerek W Bartlett, Adam M GilbertBiotechnology and Bioengineering|December 13, 2006
Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencingDerek W Bartlett, Mark E DavisJournal of Pharmacokinetics and Pharmacodynamics|October 22, 2020
A kinetic proofreading model for bispecific protein degradersDerek W Bartlett, Adam M GilbertBioconjugate Chemistry|March 1, 2007
Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticlesDerek W Bartlett, Mark E DavisNucleic Acids Research|January 18, 2006
Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imagingDerek W Bartlett, Mark E DavisBiotechnology and Bioengineering|October 12, 2007
Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticlesDerek W Bartlett, Mark E DavisBioconjugate Chemistry|August 30, 2008
Rapid and efficient production of radiolabeled antibody conjugates using vacuum diafiltration guided by mathematical modelingDerek W Bartlett, David Colcher, Andrew A RaubitschekNature Reviews. Drug Discovery|February 22, 2023
Delivering on the promise of protein degradersMatthew N O'Brien Laramy, Suman Luthra, Matthew F Brown, et al.The Journal of Biological Chemistry|May 1, 2020
Enigmatic MELK: The controversy surrounding its complex role in cancerIan M McDonald, Lee M GravesPageof 14